AstraZeneca Shares Fall on Crestor Worry
479311
Shares in AstraZeneca Plc fell as much  as 10 percent on Friday after regulators in the United States  and Europe raised safety concerns about the Anglo-Swedish drug  maker's anti-cholesterol treatment Crestor.
389867
Shares in Pfizer Inc, the world's  biggest drugmaker, fell more than 10 percent in early trade in  Europe on Monday, after news it had scrapped its most important  experimental drug.
627881
European shares retreated on Wednesday as AstraZeneca's business update disappointed investors and on nagging concerns that soaring oil prices will hurt the quality of future earnings.
353921
Twenty-nine patients who took  AstraZeneca Plc's AZN.L AZN.N anti-cholesterol drug Crestor  have developed kidney damage, a U.S. consumer group said on  Friday as it called again for a ban on the medicine.
708793
US blue-chip stocks fell on Monday as oil prices nudged higher and drug maker Pfizer Inc. (PFE) and aluminum producer Alcoa Inc. (AA) were hit by broker downgrades.
224503
Shionogi Co. shares fell as much as 14.4 percent in Tokyo on concerns in the European Union and US about the safety of Crestor, a cholesterol-reducing drug developed by the Japanese company and sold by AstraZeneca Plc.
114185
Shares drop as U.S. regulators say they want more info before approving caner medication Bonefos.
82229
Shares in GlaxoSmithKline fall after it issues a profit warning on the back of falling demand for a key drug.
277535
Shares of large U.S. and European drug makers fell on Thursday after a prominent cardiologist questioned the safety of new arthritis drugs and the performance of U.S. regulators in monitoring drug safety.
106113
Shares in AstraZeneca tumbled today after a key drug it has developed in the fight against strokes was provisionally rejected by US regulators.
455141
Leading shares in London closed lower Tuesday hit by heavy falls on Wall Street while rumours of a potential problem at a London based hedge fund offset news of a significant stake build at Cadbury Schweppes, dealers said.
132494
US stocks fell as setbacks for drugmakers, including a study showing Pfizer Inc.&#39;s Celebrex painkiller increased the risk of heart attacks, sent health-care shares tumbling.
479423
AstraZeneca Plc's cholesterol-lowering drug Crestor performed better than Pfizer Inc's Lipitor in an AstraZeneca-funded study of patients with metabolic syndrome, according to results released on Monday.
149601
Top shares have fallen to a three-week low after an early jump on the back of positive corporate news failed to gather momentum and stronger-than-expected retail sales data
179939
AstraZeneca&#39;s newest advertisements for its cholesterol-lowering drug Crestor are misleading and should be pulled from the market, consumer group Public Citizen says.
542397
AstraZeneca Plc's cholesterol-lowering drug Crestor has been linked to the death of a patient, Europe's third largest drugmaker said on Monday.
414238
Stocks inched lower on Friday,  pressured by a sharp drop in Pfizer Inc. PFE.N after the drug  maker said patients in a study showed an increased risk of  heart attacks after taking its popular Celebrex drug.